Introduction
Progressive excitotoxicity, deregulation of mitochondrial (Mt) functions, and apoptosis have been observed as major causes for pathological conditions, aging, and neurodegenerative diseases such as Parkinson's disease (PD), alzheimer's disease (aD), Multiple Sclerosis (MS) and amyolotrophic lateral sclerosis (aLS). 1 Neurodegenerative diseases display loss of nerve cells from brain and spinal cord. They have been manifested by either functional loss, ataxia, sensory dysfunction, or dementia. The Pax6, a highly conserved, multifunctional transcription factor, has been known to influence specification of neuronal subtypes in the retina and spinal cord, dorsoventral patterning, neurogenic specification, proliferation and migration in the developing cortex. The Pax6-KO (knockout) mice show embryonic lethality with loss of CNS, eyes and pancreatic alpha-cells. Studies suggest its dual role as both an activator and repressor of different target genes. [2] [3] [4] The mutations in Pax6 result in neuronal anomalies like defect in the CNS leading to cell death, 5 Polymicrogyria, absence of the pineal gland, 6 Psychiatric disorder, cognitive defects 7 and cerebral malfunctions. 8 Most of the phenotypes also match agingassociated pathological conditions. a large number of upstream effectors and downstream targets of Pax6 have either been proposed or confirmed.
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A AN NN NA AL LS S RES ARTICLE expression of GFaP in some neurodegenerative diseases. GFaP null mice have been demonstrated to be sensitive to spinal cord injury to cerebral ischemia and to neurotoxicity indicating a protective role of GFaP. 26, 27 The S100β is a low molecular weight Ca 2+ binding protein composed of two isomeric subunits found predominantly in astrocytes and Schwann cells. It plays important role in normal CNS development and recovery after injury. at nanomolar concentration, S100β stimulates neurite outgrowth in cerebral cortex neuron and enhance survival of neurons in various systems during development but at micromolar concentration, S100β may have deleterious effects i.e., it stimulates the expression of pro-inflammatory cytokines and induces apoptosis. In alzheimer's, S100β protein levels are significantly increased when β-amyloid interact with S100β and stimulate synthesis of both S100β mRNa and S100β protein in astrocytes cultures. Significant immune response to S100β suggests that it may reflect neurodegenerative brain damage occurring in Parkinson's disease. 28, 29 PCNa plays an essential role in nucleic acid metabolism as a component of the replication and repair machinery. It is a 36kDa polypeptide whose expression and synthesis is linked with cell proliferation. In neurodegenerative diseases, presence of cell cycle markers has raised the possibility that aberrant activation of the cell cycle machinery in postmitotic neuron could be lethal and contributes to neurodegeneration. 30 The PCNa has a triple function in life and death of the cells. When not engaged in DNa replication, PCNa under p53 control commits cells to cell cycle arrest and repair of DNa damage, or when repair is not possible, absence or low levels of functional PCNa may drive cells into apoptosis.
It is presumed that Pax6 regulates the neurodegeneration either through regulation of its own transcription or through the regulation of a large no. of targets involved in the maintenance of the neuronal functions. Since Pax6 is the master regulator and regulates the transcription of the genes involved in the neurogenesis and plasticity, we intended here to explore that does Pax6 involve directly or indirectly in neurodegeneration.
Methods

Maintenance of cell-lines
The cell lines having origin of murine embryonic fibroblast (Pax6-non expressing, NIH3T3-cell line), murine neuroblastoma (Pax6-expressing brain-derived, Neuro-2a-cell line), and human glioblastoma-astrocytoma (U87MG) were cultured and maintained in a CO 2 incubator at 37°C and 5% CO 2 in DMEM containing 10% fetal bovine serum. The knockdown of endogenous Pax6 in Neuro-2a cells was achieved through siRNa based gene knockdown approach. The study was ethically approved by IBSC.
Knockdown of Pax6 by siRNA and analysis of neurodegeneration-associated markers
The siRNa based gene-silencing approach was used to knock down the endogenous transcripts of Pax6 (Pax6_2, Pax6_4, Pax6_5, and Pax6_7). The siRNas targeting transcripts of Pax6 were procured from Flexi tube Gene Solution (Qiagen Inc., GmbH, Germany), and suspended to yield 10μM stock solution. The Neuro-2a was transfected with Pax6 specific siRNas and control siRNas using Human/mouse RNai starter kit (Qiagen Inc., GmbH, Germany) and Lipofectamine RNai MaX (Invitrogen, Life Technologies, USa) as per the manufacturer's instructions. The 5 nM of each of siRNas/well of the 12-well plate and/ or 250 ng per well/6-well plate were observed effective. after 72-hours of Post-transfection or after transfection total RNa was isolated from different sets of siRNa transfected-cells using Pure Link RNa mini kit (ambion, Life Technologies, USa). One microgram of the total RNa was reverse transcribed into first strand cDNa using first strand cDNa synthesis kit (High capacity cDNa synthesis kit, applied Biosystems, Life technologies, USa). The levels of putative markers Pax6, PCNA, S100beta, GFAP, Ngn2, p73alpha, p73gama, BDNF, p53, TGF-β, LDH, SOD, and Catalase, under Pax6-knockdown background, were assessed using Maxima SYBR Green qPCR Master Mix (Fermentas, USa) on aBI 7500 Real Time thermal cycler manufacturer details. Following gene specific primer sets were used: 
Results
The observations are important and interesting because they reveal several valuable aspects of understanding neuro-degeneration under Pax6 background. The Pax6, as expected was detected in Pax6 expressing cell-lines, the Neuro-2a and U-87MG cells, but not in NIH3T3 cells (Non-Pax6 expressing cell-line) (Fig. 1a) . The levels of expression of putative markers of neurodegeneration S100β, GFaP, BDNF, NGN2, p73α, p73δ, and LDH, SOD, Catalase were detectable in these cell lines (Fig 1B) . The siRNa mediated knockdown of Pax6 validated through semi quantitative RT-PCR (Fig. 2a) and real-time-PCR (Fig. 2 B-C) show effective knock-down of Pax6 and modulation in Pax6 and Pax6 (5a) transcript (Fig. 2a-C) . The expression pattern and modulation (Table 1) of neuronal-glial degenerative markers in Pax6-knockdown background suggest association of the Pax6 and these neurodegenerative markers.
Expression of Brain-derived neurotrophic factor (BDNF) was observed lower in Pax6-knockdown background. It seems critical because the BDNF has been important for the survival, maintenance and regeneration of specific neuronal population in the adult brain. Its replacement strategies are considered as potential therapeutics for neurodegenerative diseases such as Parkinson's, alzheimer's and Huntington's diseases. [31] [32] [33] Lower levels of Pcna after Pax6-knock-down clearly indicate important association with the Pax6. Being Pcna being, a nuclear matrix protein, essential for multiple cell cycle pathways, has been associated as triple function in life and death of the cells. not possible, absence or low levels of functional Pcna may drive cells into apoptosis. 34 Lower levels of Ngn2 indicate deregulation of neuronal growth and differentiation. The Ngn 2 is necessary for the proper differentiation of excitatory glutamatergic projection neurons in the cerebral cortex. Proneural transcription factors are thus critical regulators for both the initiation of neuronal differentiation and the specification of neurons into distinct regional subtypes. 35 The S100β is a β homodimeric protein, expressed in astrocytes and oligodendrocytes 36 were also observed lower. Since the S100β is a potent marker of neuro-degeneration and its down-regulation in the Pax6-null background seems equally important in association with Pax6 in neuro-degeneration. Pax6 inhibits the growth and proliferation of astrocytes and help in the maturation of astrocytes. 37 The S100β also plays neurotrophic role in both development and repair by inhibition of cell growth either by cooperating with p53 directly or is able to inhibit its synthesis, resulting in decrease in the rate of cell proliferation. 38 Thus Pax6 seems to regulate the expression of S100β, and S100β-mediated pathways. Findings are in line of some reports the loss of TGFβ results in increased microgliosis and neuro-degeneration. However, its up-regulation influences silencing of neuro-inflammation. 39 The Pax6 regulates cell proliferation, whereas p53 is critical for cell cycle regulation and cell death. Since, the interaction of Pax6 with p53 indicates Smad3 dependent auto-regulation, 40 this observation indicates critical Pax6-p53 associated regulation.
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The other two members of the p53 family were also showed lower expression in the Pax6-null background. From the expression analysis of the p53 family genes suggested that Pax6 seems to be involved directly with p53-and TGFβ-mediated pathways and indirectly with redox-sensitive pathway regulation. The other markers like SOD, LDH and Catalase were also found down regulated in Pax6-knockdown background. The levels of expression of SOD, Catalase, and TGF-β were higher in Neuro-2a than in NIH/3T3, whereas Pax6 was exclusive to Neuro-2a cells. The increased levels of SOD and Catalase have been (Fig. 3) . Observations indicate that Pax6 influences process of neuro-degeneration through all cascades of genes involved in growth, differentiation and maturation of neurons and glia. The functional analysis of Pax6 and its isoforms could be useful for exploring cascades and mechanisms of functions of Pax6-associated neuro-degenerative markers in differential diagnosis and managements of neurological problems. The neurodegenerative markers S100β, GFaP, BDNF, NGN2, p73α, p73δ, were observed down-regulated in Pax6 knockdown condition. The Pax6 seems influencing process of neuro-degeneration through cascades of genes involved in growth, differentiation and maturation of neurons and glia. It may be associated directly with p53 and TGFβ mediated pathways and indirectly with redox-sensitive pathway regulation. The functional analysis of Pax6-associated neuro-degenerative markers would be helpful in differential diagnosis and managements of neurological problems. It could be investigated that which isoform of Pax6 is responsible for normal functioning/expression of particular neurodegenerative marker that will help in the diagnosis of neurological problems.
Authorship Contribution
Rajnikant Mishra: Planned experiments and mentored the progress of experiments, from initiation to completion of manuscript, Sachin Shukla: Initiated the work and did qPCR experiments following transfection, Khushboo Srivastava: Repeated transfection experiments and isolated RNa and prepared cDNa, Shashank Kumar Maurya and Shuman Mishra: Equally contributed for RT-PCR based experiments, compiled data and wrote their part of explanations
